INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 45h ago
House PTR5h ago
SEC 13F5h ago
Robinhood Chain5h ago

Most active filers · 30d

  1. 01Kurtz George0B / 220S220 trades$52.89M
  2. 02SPSaba Capital Management, L.P.66B / 18S · 11 late84 trades$24.31M
  3. 03SJSheena Jonathan0B / 57S57 trades$3.61M
  4. 04ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  5. 05AJAllaire Jeremy0B / 50S50 trades$4.26M
  6. 06Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  7. 07RJRubinstein Julie0B / 37S37 trades$6.38M
  8. 08SLSpeiser Michael L0B / 35S35 trades$14.00M
  9. 09RARothblatt Martine A0B / 33S33 trades$5.50M
  10. 10CECrimmins David Edward0B / 31S31 trades$723K

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 108 insiders$40.91M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLMGNIMAGNITE, INC.Nov 5 – Nov 127 insiders$2.27M
  7. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  8. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M

Form 4 transactions

69,446 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
13
BH
Bohnert Christopher HSVP, Chief Financial Officer
NNBRNN INC
Tax withholding
F$25K
9,205 sh
Jun 25, 2026Jun 26, 2026
Page 629 of 1737
← PrevNext →
traded Jun 25, 2026
+1d
SEC Form 4

Evidence

13
MP
Menu PhilippeChief Medical Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$28K
5,000 sh
Jun 25, 2026Jun 26, 2026
traded Jun 25, 2026
+1dSEC Form 4

Evidence

13
VC
Van Tuyl ChristopherChief Legal Officer
IMVTImmunovant, Inc.
Option exercise
M—
17.8K sh
Jun 26, 2026Jun 26, 2026
traded Jun 26, 2026
+0dSEC Form 4

Evidence

13
HA
Hughes AaronDirector
SSentinelOne, Inc.
Grant or award
A—
4,176 sh
Jun 25, 2026Jun 26, 2026
traded Jun 25, 2026
+1dSEC Form 4

Evidence

13
RK
Rubin KevinChief Financial Officer
ZSZscaler, Inc.
Open-market sale · 10b5-1 plan
SELL$210K
1,696 sh
Jun 25, 2026Jun 26, 2026
traded Jun 25, 2026
+1dSEC Form 4

Evidence

13
DJ
DeSimone JillDirector
PRAXPraxis Precision Medicines, Inc.
Option exercise · 10b5-1 plan
M$447K
3,034 sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

13
RK
Rubin KevinChief Financial Officer
ZSZscaler, Inc.
Open-market sale · 10b5-1 plan
SELL$70K
560 sh
Jun 25, 2026Jun 26, 2026
traded Jun 25, 2026
+1dSEC Form 4

Evidence

13
FW
Frazier WilliamDirector, Chief Medical Officer
VMDVIEMED HEALTHCARE, INC.
Option exercise
M$18K
10.0K sh
Jun 25, 2026Jun 26, 2026
traded Jun 25, 2026
+1dSEC Form 4

Evidence

13
RK
Rubin KevinChief Financial Officer
ZSZscaler, Inc.
Open-market sale · 10b5-1 plan
SELL$62K
504 sh
Jun 25, 2026Jun 26, 2026
traded Jun 25, 2026
+1dSEC Form 4

Evidence

12
HM
Hancock MarkDirector, Co Fndr; Exec V Chair, 10% Owner
PACSPACS Group, Inc.
Open-market sale · 10b5-1 plan
SELL$2.50M
61.7K sh
Jun 26, 2026Jun 26, 2026
traded Jun 26, 2026
+0dSEC Form 4

Evidence

12
CL
Caldwell Jonathan L.Chief People Officer
VVVVALVOLINE INC
Open-market sale · 10b5-1 plan
SELL$114K
2,851 sh
Jun 25, 2026Jun 26, 2026
traded Jun 25, 2026
+1dSEC Form 4

Evidence

12
RD
Rabinowitz DanielSEC. AND CHIEF LEGAL OFFICER
NTRANatera, Inc.
Open-market sale · 10b5-1 plan
SELL$1.28M
5,066 sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

12
DJ
DeSimone JillDirector
PRAXPraxis Precision Medicines, Inc.
Open-market sale · 10b5-1 plan
SELL$210K
683 sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

12
BL
Burrows Scott LChief Financial Officer
SYRESpyre Therapeutics, Inc.
Option exercise
M$218K
15.0K sh
Jun 25, 2026Jun 26, 2026
traded Jun 25, 2026
+1dSEC Form 4

Evidence

12
WP
Wierbicki PaulDirector, Chief Legal Officer
RSIRush Street Interactive, Inc.
Option exercise
M$74K
6,926 sh
Jun 25, 2026Jun 26, 2026
traded Jun 25, 2026
+1dSEC Form 4

Evidence

12
DJ
DeSimone JillDirector
PRAXPraxis Precision Medicines, Inc.
Open-market sale · 10b5-1 plan
SELL$158K
504 sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

12
LW
Leibrock Robert WilliamChief Financial Officer
ACIWACI WORLDWIDE, INC.
Disposition to issuer
D$114K
2,454 sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

12
HM
Hancock MarkDirector, Co Fndr; Exec V Chair, 10% Owner
PACSPACS Group, Inc.
Open-market sale · 10b5-1 plan
SELL$5.57M
138.1K sh
Jun 25, 2026Jun 26, 2026
traded Jun 25, 2026
+1dSEC Form 4

Evidence

11
DJ
Daunt JohnEVP, Chief Commercial Officer
LQDTLIQUIDITY SERVICES INC
Open-market sale · 10b5-1 plan
SELL$296K
7,539 sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

11
ST
Sakamoto Ryan T.EVP, Chief Legal Officer
ZIPZIPRECRUITER, INC.
Open-market sale · 10b5-1 plan
SELL$11K
2,978 sh
Jun 25, 2026Jun 26, 2026
traded Jun 25, 2026
+1dSEC Form 4

Evidence

11
IN
Islam NayaabSee Remarks
STUBStubHub Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$302K
25.1K sh
Jun 26, 2026Jun 26, 2026
traded Jun 26, 2026
+0dSEC Form 4

Evidence

10
RK
Rubin KevinChief Financial Officer
ZSZscaler, Inc.
Open-market sale · 10b5-1 plan
SELL$29K
228 sh
Jun 25, 2026Jun 26, 2026
traded Jun 25, 2026
+1dSEC Form 4

Evidence

10
VE
Venker EricPresident & Immunovant CEO
ROIVRoivant Sciences Ltd.
Open-market sale · 10b5-1 plan
SELL$1.55M
46.2K sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

10
RK
Rubin KevinChief Financial Officer
ZSZscaler, Inc.
Open-market sale · 10b5-1 plan
SELL$1,521
12 sh
Jun 25, 2026Jun 26, 2026
traded Jun 25, 2026
+1dSEC Form 4

Evidence

9
BH
Baker Eric HowardDirector, See Remarks, 10% Owner
STUBStubHub Holdings, Inc.
Option exercise
M—
739.3K sh
Jun 25, 2026Jun 26, 2026
traded Jun 25, 2026
+1dSEC Form 4

Evidence

9
KP
Kowalski Jessica PatriciaEVP and GM, Research
WLYWLYBJOHN WILEY & SONS, INC.
Grant or award
A—
20.0K sh
Jun 25, 2026Jun 26, 2026
traded Jun 25, 2026
+1dSEC Form 4

Evidence

9
KM
Kelly MichaelDirector
SPRYARS Pharmaceuticals, Inc.
Grant or award
A—
30.0K sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

9
LJ
Linz Terrence JamesPresident, Wholesale Brands
LZBLA-Z-BOY INC
Tax withholding
F$20K
482 sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

9
SJ
Singh Ritadhwaja JebensEVP & CHIEF DIGITAL OFFICER
LTHLife Time Group Holdings, Inc.
Option exercise · 10b5-1 plan
M$925K
67.8K sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

9
MD
McMahan DanielleEVP, Chief People Officer
WLYWLYBJOHN WILEY & SONS, INC.
Grant or award
A—
7,987 sh
Jun 25, 2026Jun 26, 2026
traded Jun 25, 2026
+1dSEC Form 4

Evidence

9
SP
Schmitt PeterDirector
SKILSkillsoft Corp.
Option exercise
M—
12.4K sh
Jun 25, 2026Jun 26, 2026
traded Jun 25, 2026
+1dSEC Form 4

Evidence

9
BM
Burke William P. Mr.Director
AXGNAxogen, Inc.
Grant or award
A—
4,392 sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

9
BS
Boyce SarahDirector
CTNMContineum Therapeutics, Inc.
Grant or award
A—
19.0K sh
Jun 26, 2026Jun 26, 2026
traded Jun 26, 2026
+0dSEC Form 4

Evidence

9
MM
Masiello Wendy MotlongDirector
SAROStandardAero, Inc.
Grant or award
A—
6,608 sh
Jun 25, 2026Jun 26, 2026
traded Jun 25, 2026
+1dSEC Form 4

Evidence

9
RZ
Richmond Raphaell Z.VP, GC & Chief Compliance Off
LZBLA-Z-BOY INC
Tax withholding
F$20K
474 sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

9
MM
Manko Joseph M. Jr.Director
MYOMYOMO, INC.
Grant or award
A—
78.7K sh
Jun 25, 2026Jun 26, 2026
traded Jun 25, 2026
+1dSEC Form 4

Evidence

9
GW
Gilliland Arthur WDirector
SKILSkillsoft Corp.
Option exercise
M—
6,250 sh
Jun 25, 2026Jun 26, 2026
traded Jun 25, 2026
+1dSEC Form 4

Evidence

9
FM
Friedland Robert MDirector, Executive Chairman
IEIvanhoe Electric Inc.
Option exercise
M—
916.7K sh
Jun 25, 2026Jun 26, 2026
traded Jun 25, 2026
+1dSEC Form 4

Evidence

9
SP
Schmitt PeterDirector
SKILSkillsoft Corp.
Option exercise
M—
12.4K sh
Jun 25, 2026Jun 26, 2026
traded Jun 25, 2026
+1dSEC Form 4

Evidence

9
CN
Chandhok NikhilChief Product & Tech. Officer
CRCLCircle Internet Group, Inc.
Option exercise · 10b5-1 plan
M$5.16M
200.0K sh
Jun 25, 2026Jun 26, 2026
traded Jun 25, 2026
+1dSEC Form 4

Evidence